Abstract
Medical abortion with mifepristone and misoprostol is a two-step process where some
women will change their minds about going through the abortion process after taking
mifepristone. Of these, some pregnancies will continue. A woman with a twin pregnancy
who changed her mind is presented. Twin pregnancies may need higher dosages of mifepristone
than single pregnancies due to the presence of two corpora lutea and increased amount
of trophoblast tissue. There is little, if any, documentation regarding congenital
abnormalities after taking mifepristone. Therefore, there is little evidence to support
persuasion of the patient to continue the abortion process with the prostaglandin
analouge.
Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to ContraceptionAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Medical termination of pregnancy.N. Engl. J. Med. 2000; 342: 946-956
- Termination of pregnancy with reduced doses of mifepristone.BMJ. 1993; 307: 532-537
- Fetal malformation and failed medical termination of pregnancy.Lancet. 1998; 352: 323
- Termination of early pregnancy by the progesterone antagonist RU 486 (mifepristone).N. Engl. J. Med. 1986; 315: 1565-1570
- The efficacy of medical abortion: a meta-analysis.Contraception. 2000; 61: 29-40
- The endocrinology of pregnancy.in: Speroff L. Glass R.H. Kase N.G. Clinical gynecologic endocrinology and infertility. Williams & Wilkins, Baltimore1994: 251-289
- Termination of pregnancy at 9���13 weeks' amenorrhoea with mifepristone and misoprostol.Lancet. 1998; 352: 542-543
- Early pregnancy termination with mifepristone and misoprostol in the United States.N. Engl. J. Med. 1998; 338: 1241-1247
- Contragestion and other clinical applications of RU 486, an antiprogesterone at the receptor.Science. 1989; 245: 1351-1357
- Embryonic abnormalities at medical termination of pregnancy with mifepristone and misoprostol during first trimester: observational study.BMJ. 1998; 316: 1712-1713
- Development after exposure to mifepristone in early pregnancy.Lancet. 1991; 338: 763
- Normal development after exposure to mifepristone in early pregnancy.Lancet. 1990; 336: 257-258
- RU 486 abortions.Nature. 1989; 338: 110
- Development after in-utero exposure to mifepristone.Lancet. 1991; 338: 1270
- Congenital abnormalities in Brazilian children associated with misoprostol misuse in first trimester of pregnancy.Lancet. 1998; 351: 1624-1627
- Congenital malformation of the scalp and cranium after failed first trimester abortion attempt with misoprostol.Clin. Dysmorphol. 1993; 2: 76-80
- Use of misoprostol during pregnancy and Mobius' syndrome in infants.N. Engl. J. Med. 1998; 338: 1881-1885
- Epidemiological assessment of misoprostol teratogenicity.BJOG. 2000; 107: 519-523
Article info
Publication history
Accepted:
September 7,
2004
Received in revised form:
August 31,
2004
Received:
July 30,
2004
Identification
Copyright
© 2005 Elsevier Inc. Published by Elsevier Inc. All rights reserved.
